# Private Send Readiness Gate

Date checked: 2026-06-17
Status: private-send readiness gate, not contact permission and not treatment advice

## Direct Answer

The next blocker is whole-workflow readiness. The repo can now represent a
founder approval label, but a private-send workflow still needs all upstream
gates to pass together. The current state remains hold because scoped approval
and recipient qualification have not been recorded.

Current operational label:

`case001_private_send_readiness_hold_missing_approval_or_recipient`

## Required Before A Private Execution Check

| Requirement | Current state |
| --- | --- |
| Scoped approval label | Missing. |
| Recipient qualification | Missing. |
| Outbound packet pass | Founder-review packet exists from June 15. |
| Private sender and recipient handling | Must stay outside Git. |
| Response capture | June 13 gate exists and must be ready before any reply. |
| Clinical or procurement scope | Must be absent. |

## Decision Labels

| Label | Meaning |
| --- | --- |
| `private_send_hold_missing_scoped_approval` | Approval is absent, review-only, denied, expired, or not scoped to public-safe quote content. |
| `private_send_hold_missing_recipient_qualification` | No recipient class passed the June 8 gate. |
| `private_send_hold_missing_packet_pass` | The outbound packet is incomplete or stale. |
| `private_send_hold_missing_response_capture` | Future reply handling is not ready. |
| `private_send_reject_public_or_clinical_scope` | Public/private boundary, patient sample, treatment, trial, purchase, import, or procurement scope is present. |
| `private_send_ready_for_private_execution_check` | All public-safe gates pass; this still does not send or authorize clinical action. |

## Current Source Read

The June 17 PubMed refresh and direct page checks did not change this boundary.
Current PK activation, erythroid-metabolism, gamma-globin, HBG editing, and
SNH-119014 sources remain benchmark or optional-endpoint context. They do not
replace approval, recipient qualification, packet review, private handling, or
response capture.

## Islamic Motivation Boundary

Quran 49:6 supports verification before consequential action. Quran 5:2
supports bounded cooperation. Quran 4:58 supports routing trusts to the right
owner. These are process ethics only, not biomedical evidence.

## Boundary

This gate does not diagnose, select therapy, change transfusion or chelation,
screen for a trial, request a sample, buy or import a compound, select a lab, or
contact anyone.

## Sources

- [Workflow JSON](../../../data/workflows/case-001/2026-06-17-private-send-readiness-gate.json)
- [June 17 current literature refresh](../../../data/literature/pubmed/2026-06-17-private-send-readiness-refresh.json)
- [Founder approval record gate](2026-06-16-founder-approval-record-gate.md)
- [First quote outbound packet gate](2026-06-15-first-quote-outbound-packet-gate.md)
- [First quote response-capture gate](2026-06-13-first-quote-response-capture-gate.md)
- [Lab recipient qualification gate](2026-06-08-lab-recipient-qualification-gate.md)
- [Quran 49:6 verification anchor](../../islamic/quran/049-al-hujurat/006.md)
- [Quran 5:2 cooperation anchor](../../islamic/quran/005-al-maidah/002.md)
- [Quran 4:58 owner-responsibility anchor](../../islamic/quran/004-an-nisa/058.md)
- [PubMed PMID `41184165`](https://pubmed.ncbi.nlm.nih.gov/41184165/)
- [Frontiers SNH-119014 source](https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1719328/full)
